S
Syncom Formulations (India) Ltd
NSE:SYNCOMF
Syncom Formulations (India) Ltd
NSE:SYNCOMF
Price:
12.31
INR
-3.75%
Market Closed
Market Cap:
₹11.6B
Relative Value
The Relative Value of one SYNCOMF stock under the Base Case scenario is hidden INR. Compared to the current market price of 12.31 INR, Syncom Formulations (India) Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SYNCOMF Relative Value
HIDDEN
Multiples Across Competitors
SYNCOMF Competitors Multiples
Syncom Formulations (India) Ltd Competitors
Syncom Formulations (India) Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
S
|
Syncom Formulations (India) Ltd
NSE:SYNCOMF
|
11.6B INR | 2.3 | 16.8 | 13.8 | 14.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
951.3B USD | 14.6 | 46.1 | 31.1 | 33.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
595.7B USD | 6.3 | 22.2 | 15.4 | 18.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
282B CHF | 4.6 | 29.9 | 12.7 | 14.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
244.9B CHF | 5.6 | 22.4 | 13.8 | 17.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
231.2B GBP | 5.3 | 30.4 | 16.8 | 23.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
297.5B USD | 4.6 | 16.3 | 10.1 | 12.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.2 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
151.6B USD | 2.4 | 19.5 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124.5B USD | 2.6 | 17.6 | 7.4 | 9.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
